Bioactivities by a crude extract from the Greenlandic Pseudomonas sp. In5 involves the nonribosomal peptides, nunamycin and nunapeptin

Background. Bioactive microbial metabolites provide a successful source of novel compounds with pharmaceutical potentials. The bacterium Pseudomonas sp. In5 is a biocontrol strain isolated from a plant disease suppressive soil in Greenland, which produces two antimicrobial nonribosomal peptides (NRPs), nunapeptin and nunamycin. Methods. In this study, we used in vitro antimicrobial and anticancer bioassays to evaluate the potential bioactivities of both a crude extract derived from Pseudomonas sp. In5 and NRPs purified from the crude extract. Results. We verified that the crude extract derived from Pseudomonas sp. In5 showed suppressive activity against the basidiomycete Rhizoctonia solani by inducing a mitochondrial stress-response. Furthermore, we confirmed suppressive activity against the oomycete Pythium aphanidermatum by the Pseudomonas sp. In5 crude extract, and that the purified nunamycin and nunapeptin displayed distinct antimicrobial activities. In addition to the antimicrobial activity, we found that treatment of the cancer cell lines, Jurkat T-cells, Granta cells, and melanoma cells, with the Pseudomonas sp. In5 crude extract increased staining with the apoptotic marker Annexin V while no staining of healthy normal cells, i.e., naïve or activated CD4 T-cells, was observed. Treatment with either of the NRPs alone did not increase Annexin V staining of the Jurkat T-cells, despite individually showing robust antimicrobial activity, whereas an anticancer activity was detected when nunamycin and nunapeptin were used in combination. Discussion. Our results suggest that the bioactivity of a crude extract derived from Pseudomonas sp. In5 involves the presence of both nunamycin and nunapeptin and highlight the possibility of synergy between multiple microbial metabolites.

[1]  D. Murray,et al.  Romidepsin targets multiple survival signaling pathways in malignant T cells , 2015, Blood Cancer Journal.

[2]  P. Permi,et al.  Antifungal Compounds from Cyanobacteria , 2015, Marine drugs.

[3]  P. Dorrestein,et al.  Nonribosomal Peptides, Key Biocontrol Components for Pseudomonas fluorescens In5, Isolated from a Greenlandic Suppressive Soil , 2015, mBio.

[4]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[5]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[6]  P. Permi,et al.  Anabaenolysins, Novel Cytolytic Lipopeptides from Benthic Anabaena Cyanobacteria , 2012, PloS one.

[7]  C. F. Michelsen,et al.  Hydrogen cyanide synthesis and antifungal activity of the biocontrol strain Pseudomonas fluorescens In5 from Greenland is highly dependent on growth medium. , 2012, Canadian journal of microbiology.

[8]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[9]  M. Mazzola,et al.  Diversity and natural functions of antibiotics produced by beneficial and plant pathogenic bacteria. , 2012, Annual review of phytopathology.

[10]  Nicholas H Oberlies,et al.  Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma , 2011, The Journal of Antibiotics.

[11]  C. F. Michelsen,et al.  A Novel Antifungal Pseudomonas fluorescens Isolated from Potato Soils in Greenland , 2011, Current Microbiology.

[12]  Manuel T. Silva Secondary necrosis: The natural outcome of the complete apoptotic program , 2010, FEBS letters.

[13]  O. Nybroe,et al.  Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics. , 2010, FEMS microbiology reviews.

[14]  Pavel A Pevzner,et al.  Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis , 2010, Proceedings of the National Academy of Sciences.

[15]  Gregory Kucherov,et al.  Diversity of Monomers in Nonribosomal Peptides: towards the Prediction of Origin and Biological Activity , 2010, Journal of bacteriology.

[16]  A. Rinaldi,et al.  Lipopeptides as anti-infectives: a practical perspective , 2009, Central European Journal of Biology.

[17]  H. Wösten,et al.  Cytoplasmic Continuity Revisited: Closure of Septa of the Filamentous Fungus Schizophyllum commune in Response to Environmental Conditions , 2009, PloS one.

[18]  A. Demain,et al.  Microbial drug discovery: 80 years of progress , 2009, The Journal of Antibiotics.

[19]  S. Sindhu Biological Control of Soilborne Plant Pathogens with Rhizosphere Bacteria , 2009 .

[20]  D. Hoskin,et al.  Studies on anticancer activities of antimicrobial peptides. , 2008, Biochimica et biophysica acta.

[21]  Michael G Thomas,et al.  Nonribosomal peptide synthetases involved in the production of medically relevant natural products. , 2008, Molecular pharmaceutics.

[22]  F. Peláez,et al.  Biodiversity, chemical diversity and drug discovery. , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[23]  Margherita Sosio,et al.  Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. , 2007, Natural product reports.

[24]  Yi-Qiang Cheng,et al.  Characterization of a Gene Cluster Responsible for the Biosynthesis of Anticancer Agent FK228 in Chromobacterium violaceum No. 968 , 2007, Applied and Environmental Microbiology.

[25]  D. Weller Pseudomonas biocontrol agents of soilborne pathogens: looking back over 30 years. , 2007, Phytopathology.

[26]  U. Sauerland Early Features , 2007 .

[27]  I. de Bruijn,et al.  Cyclic lipopeptide production by plant-associated Pseudomonas spp.: diversity, activity, biosynthesis, and regulation. , 2006, Molecular plant-microbe interactions : MPMI.

[28]  M. T. Pedersen,et al.  Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. , 2005, Cancer research.

[29]  B. Robinson,et al.  Immunotherapy and chemotherapy — a practical partnership , 2005, Nature Reviews Cancer.

[30]  D. Haas,et al.  Biological control of soil-borne pathogens by fluorescent pseudomonads , 2005, Nature Reviews Microbiology.

[31]  S. Cameotra,et al.  Recent applications of biosurfactants as biological and immunological molecules. , 2004, Current opinion in microbiology.

[32]  C. Reutelingsperger,et al.  Early Features of Apoptosis Detected by Four Different Flow Cytometry Assays , 1998, Apoptosis.

[33]  M. Vitale,et al.  Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes , 1993, Histochemistry.

[34]  M. Gottesman Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[35]  D. Gross,et al.  Pseudomonas syringae Phytotoxins: Mode of Action, Regulation, and Biosynthesis by Peptide and Polyketide Synthetases , 1999, Microbiology and Molecular Biology Reviews.

[36]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[37]  D. Read,et al.  The use of the fluorescent dye, 3,3'-dihexyloxacarbocyanine iodide, for selective staining of ascomycete fungi associated with liverwort rhizoids and ericoid mycorrhizal roots. , 1991, The New phytologist.

[38]  David M. Weller,et al.  Biological control of soilborne plant pathogens in the rhizosphere with bacteria , 1988 .

[39]  J. Whipps EFFECT OF MEDIA ON GROWTH AND INTERACTIONS BETWEEN A RANGE OF SOIL‐BORNE GLASSHOUSE PATHOGENS AND ANTAGONISTIC FUNGI , 1987 .